Calreticulin mutation specific CAL2 immunohistochemistry accurately identifies rare calreticulin mutations in myeloproliferative neoplasms.
Mózes R, Gángó A, Sulák A, Vida L, Reiniger L, Timár B, Krenács T, Alizadeh H, Masszi T, Gaál-Weisinger J, Demeter J, Csomor J, Matolcsy A, Kajtár B, Bödör C.
Mózes R, et al. Among authors: vida l.
Pathology. 2019 Apr;51(3):301-307. doi: 10.1016/j.pathol.2018.11.007. Epub 2018 Dec 31.
Pathology. 2019.
PMID: 30606612